Answer
Yes, JERAYGO is contraindicated in patients with severe hepatic impairment (Child-Pugh class C), with or without cirrhosis.
Sources for this answer
- JERAYGO 12.5 mg film-coated tabletsIdorsia Pharmaceuticals UK Ltd · emc · SmPC §4.3 Contraindications · Version 1Document updated
Sources checked